Patents by Inventor Ann Bethea Begovich

Ann Bethea Begovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
    Patent number: 7833706
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with rheumatoid arthritis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: November 16, 2010
    Assignee: Celera Corporation
    Inventors: Ann Bethea Begovich, Victoria Elizabeth Hope Carlton, Steven Jon Schrodi, Heather Camille Alexander
  • Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
    Patent number: 7811794
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with rheumatoid arthritis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: October 12, 2010
    Assignee: Celera Corporation
    Inventors: Michele Cargill, Ann Bethea Begovich, Heather Camille Alexander
  • GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF
    Publication number: 20100215645
    Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with rheumatoid arthritis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
    Type: Application
    Filed: May 4, 2010
    Publication date: August 26, 2010
    Applicant: CELERA CORPORATION
    Inventors: Michele CARGILL, Ann Bethea BEGOVICH, Victoria Elizabeth Hope CARLTON, Steven Jon SCHRODI, Heather Camille ALEXANDER
  • TCF-1 nucleotide sequence variation
    Patent number: 6656691
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: December 2, 2003
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg
  • TCF-1 nucleotide sequence variation
    Publication number: 20030203395
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Application
    Filed: June 4, 2003
    Publication date: October 30, 2003
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca` Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg
  • TCF-1 nucleotide sequence variation
    Publication number: 20030054350
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Application
    Filed: July 12, 2001
    Publication date: March 20, 2003
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg